广泛性真皮黑素细胞增多症的基因发现揭示多种镶嵌性病因
本研究对47例仅表现为广泛性真皮黑素细胞增多症(EDM)的患儿进行表型分析与靶向深部二代测序,发现40%(19/47)存在眼部受累,且不限于眼周皮损;5例接受MRI者中2例有缺血性梗死证据;除GNAQ外,还发现HRAS、ACTB、PIK3CA和GNA11的镶嵌变异。作者建议即使无眼周皮损也应行眼科检查,并依据基因型进行遗传咨询。
要点
- EDM需与常见蓝斑及先天性黑素细胞痣鉴别,眼部受累率高达40%。
- 除GNAQ外,HRAS、ACTB、PIK3CA、GNA11镶嵌变异也可导致EDM。
- 建议所有EDM患儿行眼科检查,有神经系统疑虑时行头颅MRI。
核心结论
- EDM由多种镶嵌性基因变异引起,包括HRAS、ACTB、PIK3CA和GNA11,扩展了已知的致病基因谱。
- EDM患者眼部受累常见且不限于眼周皮损,应常规筛查。
- 基因型分层可能有助于未来更准确评估黑素瘤风险。
研究设计与样本
- 研究纳入47例仅表现为EDM的儿科患者,进行表型分析与受累皮肤的靶向深部二代测序。
- 常规行眼科检查,5例临床怀疑神经系统异常者行头颅MRI。
主要发现
- 眼部受累见于40%(n=19/47)的患者,且不限于眼周皮肤受累者。
- 5例接受MRI的患者中2例存在缺血性梗死证据。
- 发现HRAS、ACTB、PIK3CA和GNA11的镶嵌变异,以及更多GNAQ镶嵌变异病例。
- HRAS变异此前曾报道于胚系导致Costello综合征和Noonan综合征。
临床怎么用
- 临床需将EDM与常见蓝斑区分,并推荐即使无眼周皮损也进行眼科检查。
- 中枢神经系统梗死关联尚不明确,但建议关注神经系统症状,有疑虑时行MRI。
- 存在胚系传播风险时(如该HRAS变异),应提供患者及变异特异性遗传咨询。
- 未来可依据基因型分层评估患者黑素瘤风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Extensive or atypical dermal melanocytosis (EDM) is abnormal macular blue/black skin pigmentation that can be associated with other congenital abnormalities and an increased risk of melanoma. It is probably underdiagnosed due to phenotypic overlap with common transient dermal melanocytosis (so-called 'blue spots'), and is frequently misdiagnosed as congenital melanocytic naevi. The genetic cause has remained largely unknown, with mosaic variants in only one gene, GNAQ, described in only a handful of cases to date. OBJECTIVES: To improve our understanding of EDM by combining deep phenotyping with genetic investigations in a large paediatric cohort. METHODS: Forty-seven patients with EDM only were recruited for phenotypic and targeted deep next-generation sequencing of affected skin. Ophthalmological examination was performed routinely, and magnetic resonance imaging (MRI) of the central nervous system (CNS) performed in five patients where there was clinical suspicion of neurological abnormalities. RESULTS: Ophthalmological involvement was seen in 40% (n = 19/47) of patients. Importantly, this was not restricted to those with periocular cutaneous involvement. Two of five patients who underwent MRI had evidence of ischaemic infarcts. Previously undescribed mosaic causes of EDM were found in HRAS, ACTB, PIK3CA and GNA11, alongside further cases of mosaic GNAQ. The HRAS variant has previously been reported in the germline causing Costello and Noonan syndromes. CONCLUSIONS: Clinically, our findings highlight the importance of differentiating EDM from common blue spots, and we recommend ophthalmological investigation even in the absence of periocular cutaneous involvement. The association with CNS infarct is unclear, but we suggest clinical neurological features be sought and MRI performed if there are concerns. Genetically, these results not only expand the causative genotypes of EDM, but also challenge our concept of the mosaic disorders currently described in association with HRAS, ACTB, PIK3CA and GNA11 variants. Stratification by genotype may help determine patient melanoma risk more accurately in the future. Patient- and variant-specific genetic counselling should be given where there is a potential risk of germline transmission to offspring as for this HRAS variant. Extensive or atypical dermal melanocytosis are large flat blue/grey birthmarks. We refer to them as ‘EDM’ for short. They can be overlooked or misdiagnosed, because they are similar to common, harmless ‘blue spots’ on the skin. However, it is important to identify EDM correctly. These birthmarks are caused by genetic changes in the skin, and they can be associated with problems in other parts of the body. For example, there have been links with the eyes, including a type of cancer of the skin or eye. In this study, we included 47 children with EDM. We found four new genetic causes to add to the one genetic cause that was already known. We also found that a large proportion of children with EDM also had eye problems, even if the birthmarks did not involve the skin around the eye. These findings highlight the importance of differentiating children with EDM from children with the common ‘blue spots’. The results also add to our understanding of the genetics of many different birthmark disorders. This could help improve our ability to predict the risk of skin cancer more accurately in the future.
引用
- Knöpfel N, Barberan-Martin S, Polubothu S, et al. Gene discovery in extensive dermal melanocytosis reveals multiple mosaic causes. Br J Dermatol. 2026. PMID: 41308076. doi:10.1093/bjd/ljaf481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。